Nasdaq dbtx.

BOSTON, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...BOSTON, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Feb 12, 2021 · Director. 02/17/2021. Acquisition (Non Open Market) Indirect. 3,278,526. 2,732,106. Back to DBTX Overview. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the ... Feb 9, 2023 · BOSTON, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...

BOSTON, May 17, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...

Decibel Therapeutics Description. Decibel Therapeutics Inc is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders. It aims to restore and improve hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support ...To get a sense of who is truly in control of Decibel Therapeutics, Inc. (NASDAQ:DBTX), it is important to understand the ownership structure of the business. We can see that private equity firms ...

BOSTON, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Find the latest press releases from Decibel Therapeutics, Inc. Common Stock (DBTX) at Nasdaq.com.Baird Downgrades Decibel Therapeutics (DBTX) msn.com - August 10 at 1:37 PM: Decibel Therapeutics, Inc. (NASDAQ:DBTX) surges 80%; private equity firms who own 41% shares profited along with institutions finance.yahoo.com - August 10 at 7:43 AM: Complaints about airplane noise rise at Reagan National, Dulles washingtonpost.com - …Shareholders will receive $4.0000 and 1 share of DBTX^ for each share of DBTX previously held. ... NASDAQ. Copy link to clipboard. June 1, 2021. June 1, 2021.

BOSTON, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...

DBTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Decibel Therapeutics, Inc. Is Fair to Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Decibel Therapeutics, Inc. (NASDAQ: DBTX) to Regeneron Pharmaceuticals, Inc. is fair to Decibel shareholders.

18-Sept-2023 ... Decibel Therapeutics, Inc. (Nasdaq: DBTX), relating to its proposed acquisition by Regeneron Pharmaceuticals, Inc. Under the terms of the tender ...BOSTON, March 30, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Upgrades ScotiaBank upgraded the previous rating for Primo Water Corp (NYSE:PRMW) from Sector Perform to Outperform. Primo Water earned ...06-Sept-2023 ... Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)'s sale to Nautic Partners for $10.50 in cash per share. If you are a Tabula Rasa shareholder, click ...DECIBEL THERAPEUTICS, INC. Add to a list PDF Report Decibel Therapeutics, Inc. Stock price Equities DBTX US24343R1068 Biotechnology & Medical Research Summary Charts News Calendar Company Funds and ETFs -40% on all our subscriptions* Enjoy this offer * See conditions on website Chart Decibel Therapeutics, Inc. Duration Period Style Dynamic Chart BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...BOSTON, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...

Shareholders will receive $4.0000 and 1 share of DBTX^ for each share of DBTX previously held. ... NASDAQ. Copy link to clipboard. June 1, 2021. June 1, 2021.BOSTON, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Feb 24, 2021 · BOSTON, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage company developing treatments to restore and improve hearing and balance, presented preclinical data ... BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...To get a sense of who is truly in control of Decibel Therapeutics, Inc. (NASDAQ:DBTX), it is important to understand the ownership structure of the business. We can see that private equity firms ...Find the latest news headlines from Decibel Therapeutics, Inc. Common Stock (DBTX) at Nasdaq.com.

BOSTON, March 28, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...

BOSTON, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...BOSTON, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Nov 30, 2023 · Decibel Therapeutics Description. Decibel Therapeutics Inc is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders. It aims to restore and improve hearing and balance through the restoration and regeneration of functional hair cells and non-sensory support ... BOSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Find the latest Financials data for Decibel Therapeutics, Inc. Common Stock (DBTX) at Nasdaq.com.BOSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...BOSTON, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...BOSTON, June 28, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Dec 11, 2021 · To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com. Media Contact Emily Pan [email protected] +1 (646 ...

BOSTON, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...

Oct 27, 2023 · The average twelve-month price prediction for Decibel Therapeutics is $8.45 with a high price target of $23.00 and a low price target of $2.00. Learn more on DBTX's analyst rating history. Do Wall Street analysts like Decibel Therapeutics more than its competitors?

BOSTON, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Follow. BOSTON, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to ...Decibel Therapeutics, Inc. Common Stock (DBTX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.BOSTON, May 02, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...09-Aug-2023 ... Among that is why shares of Wheels Up Experience (NYSE:UP), Decibel Therapeutics (NASDAQ:DBTX) and DraftKings (NASDAQ:DKNG) stock are on the ...BOSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...May 11, 2023 · Fintel reports that on May 12, 2023, HC Wainwright & Co. reiterated coverage of Decibel Therapeutics (NASDAQ:DBTX) with a Buy recommendation. Analyst Price Forecast Suggests 272.02% Upside. As of ... The Health Care SPDR (XLV) was up 0.42%, and the iShares NASDAQ Biotechnology Index (IBB) was recently advancing by 0.04%. Health Care Sector Update for 06/28/2022: KZR, STRO, DBTX, XLV, IBB ...... DBTX, DECIBEL THERAPEUTICS INC. DCPH, DECIPHERA PHARMACEUTICALS INC. DECN, DECISION DIAGNOSTICS DECN. DEDVF, DECISIVE DIVID CORP COM CANADA DEDVF. DMFG, DECKER ...So, the natural question for Decibel Therapeutics (NASDAQ:DBTX) shareholders is whether they should be concerned by its rate of cash burn. For the …On July 20, investment advisory Deutsche Bank maintained a Buy rating on Indie Semiconductor, Inc. (NASDAQ:INDI) stock and lowered the price target to $10 from $11. Analyst Ross Seymore issued the ...

The European Commission (EC) granted orphan drug designation to Decibel Therapeutics' (NASDAQ:DBTX) gene therapy DB-OTO to treat profound, congenital hearing loss caused by mutations of the ...Decibel intends to initiate the Phase 1/2 clinical trial of DB-OTO in the first half of 2023. BOSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage ...If you’re familiar with investing, then you’ve probably heard of major stock exchanges like the New York Stock Exchange or the NASDAQ. Stock exchanges are sort of like a mixture between an auction house and a marketplace where investors can...Find the latest dividend history for Decibel Therapeutics, Inc. Common Stock (DBTX) at Nasdaq.com. Instagram:https://instagram. nvda forecast 2023aidoge scambest site to invest in startupsis openai a publicly traded company BOSTON, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ... lucd stocksix flags stocks BOSTON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ... funded options trading account The deal also has an additional contingent payment of $3.50 per share for DBTX stock if certain milestones are met. At the $4 price for DBTX stock, this offer represents a 43.3% premium over its ...Find the latest news headlines from Decibel Therapeutics, Inc. Common Stock (DBTX) at Nasdaq.com.Fintel reports that on May 12, 2023, HC Wainwright & Co. reiterated coverage of Decibel Therapeutics (NASDAQ:DBTX) with a Buy recommendation. Analyst Price Forecast Suggests 272.02% Upside. As of ...